A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) : results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

Authors
Publication date
1 January 2019
Publisher

Abstract

C

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Ghent University Academic Bibliography

    redirect
    oaioai:archive.ugent.be:8653715
    Last time updated on 18/03/2020